Home/Pipeline/Wearable Therapeutic Ultrasound

Wearable Therapeutic Ultrasound

Advanced Peripheral Arterial Disease (PAD) and Critical Limb Ischemia (CLI)

Phase 2Active

Key Facts

Indication
Advanced Peripheral Arterial Disease (PAD) and Critical Limb Ischemia (CLI)
Phase
Phase 2
Status
Active
Company

About Vibrato Medical

Vibrato Medical is an early-stage, pre-revenue medical device innovator targeting a significant unmet need in vascular disease. The company's core technology is a first-of-its-kind wearable therapeutic ultrasound device designed to noninvasively promote vasodilation and angiogenesis (new blood vessel growth) in patients with advanced PAD and CLI, potentially offering a limb-saving alternative to invasive revascularization procedures. Backed by NIH grant funding (R44HL156543) and led by an experienced CTO with a history of medical device development and exits, Vibrato is initiating its first clinical trials to demonstrate safety and efficacy. If successful, its home-use platform could disrupt the standard of care for millions of patients worldwide.

View full company profile